<p>Wealthquest Corp 在第一季度购买了 Amedisys, Inc. (NASDAQ:AMED - 免费报告) 的新股份，根据该公司最近向证券交易委员会 (SEC) 提交的 13F 文件显示。这家机构投资者购买了 13,516 股该健康服务提供商的股票，价值约为 1,310,000 美元。</p>
<p>其他一些对冲基金最近也调整了对 AMED 的持股。挪威银行在第四季度购买了价值 83,061,000 美元的 Amedisys 新股份。Pentwater Capital Management LP 在第四季度将其对 Amedisys 的持股增加了 178.3%。Pentwater Capital Management LP 现在拥有 1,180,000 股该健康服务提供商的股票，价值 107,132,000 美元，此前在上个季度又收购了 756,000 股。AQR Arbitrage LLC 在第四季度将其对 Amedisys 的持股增加了 59.1%。AQR Arbitrage LLC 现在拥有 471,965 股该健康服务提供商的股票，价值 42,812,000 美元，此前在上个季度又收购了 175,311 股。多伦多道明银行在第四季度购买了价值 15,801,000 美元的 Amedisys 新股份。最后，CIBRA Capital Ltd 在第一季度将其对 Amedisys 的持股增加了 359.7%。CIBRA Capital Ltd 现在拥有 216,775 股该健康服务提供商的股票，价值 20,080,000 美元，此前在上个季度又收购了 169,616 股。对冲基金和其他机构投资者持有该公司 94.36% 的股票。</p>
<h2>Amedisys 价格表现</h2>
<p>NASDAQ:AMED 的股票在周四开盘价为 98.69 美元。该公司的流动比率为 1.29，速动比率为 1.29，债务与股本比率为 0.27。Amedisys, Inc. 的一年低点为 82.15 美元，一年高点为 98.77 美元。该公司的 50 日简单移动平均为 96.55 美元，200 日简单移动平均为 94.07 美元。该公司的市值为 32.4 亿美元，市盈率为 38.40，市盈增长比率为 1.33，贝塔值为 0.94。</p>
<p>Amedisys (NASDAQ:AMED - 获取免费报告) 最近在 7 月 29 日星期二发布了其财报。该健康服务提供商报告本季度每股收益为 1.54 美元，超出市场共识预期的 1.39 美元，超出 0.15 美元。Amedisys 的股本回报率为 13.09%，净利润率为 3.56%。该公司本季度的收入为 6.2186 亿美元，而分析师预期为 6.1461 亿美元。去年同期，该公司每股收益为 0.98 美元。与去年同期相比，该公司的收入增长了 5.2%。整体来看，卖方分析师预测 Amedisys, Inc. 本财年的每股收益将达到 4.4 美元。</p>
<h2>华尔街分析师预测增长</h2>
<p>几位分析师最近对 AMED 股票发布了报告。加拿大皇家银行在 4 月 16 日星期三重申了对 Amedisys 的 &#34;跑赢大盘&#34; 评级，并设定了 100.00 美元的目标价。华尔街 Zen 在 5 月 24 日星期六将 Amedisys 的评级从 &#34;强力买入&#34; 下调至 &#34;买入&#34;。</p>
<p><strong>阅读我们关于 AMED 的最新研究报告</strong></p>
<h2>关于 Amedisys</h2>
<p>(免费报告)</p>
<p>Amedisys, Inc. 及其子公司在美国提供医疗服务。它通过三个部门运营：家庭健康、临终关怀和高强度护理。家庭健康部门为患者从手术、慢性疾病或绝症中恢复提供一系列服务，并通过其专业护士预防可避免的住院再入；护理服务、专注于物理、语言和职业治疗的康复治疗师；以及社工和助理来协助患者。</p>
<h2>推荐故事</h2>
<ul>
<li>五只我们更看好的股票，胜过 Amedisys</li>
<li>高分红 REIT：它们是理想的多元化方式吗？</li>
<li>Visa 超过第三季度盈利预期，市场为何恐慌？</li>
<li>英国市场假期有哪些？如何投资和交易</li>
<li>Marvell 如何从短期目标变成突破明星</li>
<li>宝洁 NYSE: PG 在不稳定的指引后回落</li>
<li>Palo Alto Networks：全能网络安全巨头</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QU1FRA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QU1FRA"/></p>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。如对该故事有任何问题或意见，请发送电子邮件至 contact@marketbeat.com.</em></p>
<h2>你现在应该投资 1,000 美元在 Amedisys 吗？</h2>
<p>在你考虑 Amedisys 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其向客户推荐的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 Amedisys 并不在名单上。</p>
<p>虽然 Amedisys 目前在分析师中获得了适度买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>查看这五只股票</p>

阿米斯医疗

<p>Wealthquest Corp 在第一季度收购了 Amedisys, Inc.（NASDAQ:AMED）的新股份，购买了 13,516 股，价值约为 131 万美元，具体情况在其最近的 SEC 文件中披露。其他机构投资者也增加了对 Amedisys 的持股，其中挪威银行和 Pentwater Capital Management 的购买尤为显著。Amedisys 报告的季度每股收益为 1.54 美元，超出预期，收入为 6.2186 亿美元，同比增长 5.2%。分析师对该股票保持乐观，当前股价为 98.69 美元</p>

<p>Wealthquest Corp bought a new stake in Amedisys, Inc. (NASDAQ:AMED - Free Report) in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 13,516 shares of the health services provider's stock, valued at approximately $1,310,000.</p>
<div class="lb-trans"><p>Wealthquest Corp 在第一季度购买了 Amedisys, Inc. (NASDAQ:AMED - 免费报告) 的新股份，根据该公司最近向证券交易委员会 (SEC) 提交的 13F 文件显示。这家机构投资者购买了 13,516 股该健康服务提供商的股票，价值约为 1,310,000 美元。</p>
</div><p>A number of other hedge funds also recently modified their holdings of AMED. Norges Bank purchased a new stake in shares of Amedisys in the fourth quarter valued at $83,061,000. Pentwater Capital Management LP raised its holdings in shares of Amedisys by 178.3% during the fourth quarter. Pentwater Capital Management LP now owns 1,180,000 shares of the health services provider's stock worth $107,132,000 after acquiring an additional 756,000 shares in the last quarter. AQR Arbitrage LLC raised its holdings in shares of Amedisys by 59.1% during the fourth quarter. AQR Arbitrage LLC now owns 471,965 shares of the health services provider's stock worth $42,812,000 after acquiring an additional 175,311 shares in the last quarter. Toronto Dominion Bank purchased a new stake in shares of Amedisys during the fourth quarter worth $15,801,000. Finally, CIBRA Capital Ltd raised its holdings in shares of Amedisys by 359.7% during the first quarter. CIBRA Capital Ltd now owns 216,775 shares of the health services provider's stock worth $20,080,000 after acquiring an additional 169,616 shares in the last quarter. Hedge funds and other institutional investors own 94.36% of the company's stock.</p>
<div class="lb-trans"><p>其他一些对冲基金最近也调整了对 AMED 的持股。挪威银行在第四季度购买了价值 83,061,000 美元的 Amedisys 新股份。Pentwater Capital Management LP 在第四季度将其对 Amedisys 的持股增加了 178.3%。Pentwater Capital Management LP 现在拥有 1,180,000 股该健康服务提供商的股票，价值 107,132,000 美元，此前在上个季度又收购了 756,000 股。AQR Arbitrage LLC 在第四季度将其对 Amedisys 的持股增加了 59.1%。AQR Arbitrage LLC 现在拥有 471,965 股该健康服务提供商的股票，价值 42,812,000 美元，此前在上个季度又收购了 175,311 股。多伦多道明银行在第四季度购买了价值 15,801,000 美元的 Amedisys 新股份。最后，CIBRA Capital Ltd 在第一季度将其对 Amedisys 的持股增加了 359.7%。CIBRA Capital Ltd 现在拥有 216,775 股该健康服务提供商的股票，价值 20,080,000 美元，此前在上个季度又收购了 169,616 股。对冲基金和其他机构投资者持有该公司 94.36% 的股票。</p>
</div><h2>Amedisys Price Performance</h2>
<div class="lb-trans"><h2>Amedisys 价格表现</h2>
</div><p>Shares of NASDAQ:AMED opened at $98.69 on Thursday. The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 0.27. Amedisys, Inc. has a 1 year low of $82.15 and a 1 year high of $98.77. The business has a fifty day simple moving average of $96.55 and a 200 day simple moving average of $94.07. The firm has a market cap of $3.24 billion, a price-to-earnings ratio of 38.40, a P/E/G ratio of 1.33 and a beta of 0.94.</p>
<div class="lb-trans"><p>NASDAQ:AMED 的股票在周四开盘价为 98.69 美元。该公司的流动比率为 1.29，速动比率为 1.29，债务与股本比率为 0.27。Amedisys, Inc. 的一年低点为 82.15 美元，一年高点为 98.77 美元。该公司的 50 日简单移动平均为 96.55 美元，200 日简单移动平均为 94.07 美元。该公司的市值为 32.4 亿美元，市盈率为 38.40，市盈增长比率为 1.33，贝塔值为 0.94。</p>
</div><p>Amedisys (NASDAQ:AMED - Get Free Report) last posted its earnings results on Tuesday, July 29th. The health services provider reported $1.54 earnings per share for the quarter, beating the consensus estimate of $1.39 by $0.15. Amedisys had a return on equity of 13.09% and a net margin of 3.56%. The company had revenue of $621.86 million for the quarter, compared to analyst estimates of $614.61 million. During the same period last year, the company earned $0.98 earnings per share. The business's revenue was up 5.2% compared to the same quarter last year. As a group, sell-side analysts predict that Amedisys, Inc. will post 4.4 earnings per share for the current fiscal year.</p>
<div class="lb-trans"><p>Amedisys (NASDAQ:AMED - 获取免费报告) 最近在 7 月 29 日星期二发布了其财报。该健康服务提供商报告本季度每股收益为 1.54 美元，超出市场共识预期的 1.39 美元，超出 0.15 美元。Amedisys 的股本回报率为 13.09%，净利润率为 3.56%。该公司本季度的收入为 6.2186 亿美元，而分析师预期为 6.1461 亿美元。去年同期，该公司每股收益为 0.98 美元。与去年同期相比，该公司的收入增长了 5.2%。整体来看，卖方分析师预测 Amedisys, Inc. 本财年的每股收益将达到 4.4 美元。</p>
</div><h2>Wall Street Analysts Forecast Growth</h2>
<div class="lb-trans"><h2>华尔街分析师预测增长</h2>
</div><p>Several analysts recently issued reports on AMED shares. Royal Bank Of Canada reiterated an &#34;outperform&#34; rating and set a $100.00 price objective on shares of Amedisys in a report on Wednesday, April 16th. Wall Street Zen lowered Amedisys from a &#34;strong-buy&#34; rating to a &#34;buy&#34; rating in a report on Saturday, May 24th.</p>
<div class="lb-trans"><p>几位分析师最近对 AMED 股票发布了报告。加拿大皇家银行在 4 月 16 日星期三重申了对 Amedisys 的 &#34;跑赢大盘&#34; 评级，并设定了 100.00 美元的目标价。华尔街 Zen 在 5 月 24 日星期六将 Amedisys 的评级从 &#34;强力买入&#34; 下调至 &#34;买入&#34;。</p>
</div><p><strong>Read Our Latest Research Report on AMED</strong></p>
<div class="lb-trans"><p><strong>阅读我们关于 AMED 的最新研究报告</strong></p>
</div><h2>About Amedisys</h2>
<div class="lb-trans"><h2>关于 Amedisys</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>(免费报告)</p>
</div><p>Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.</p>
<div class="lb-trans"><p>Amedisys, Inc. 及其子公司在美国提供医疗服务。它通过三个部门运营：家庭健康、临终关怀和高强度护理。家庭健康部门为患者从手术、慢性疾病或绝症中恢复提供一系列服务，并通过其专业护士预防可避免的住院再入；护理服务、专注于物理、语言和职业治疗的康复治疗师；以及社工和助理来协助患者。</p>
</div><h2>Recommended Stories</h2>
<div class="lb-trans"><h2>推荐故事</h2>
</div><ul>
<li>Five stocks we like better than Amedisys</li>
<li>High Dividend REITs: Are They an Ideal Way to Diversify?</li>
<li>Visa Beats Q3 Earnings Expectations, So Why Did the Market Panic?</li>
<li>What Are the U.K. Market Holidays? How to Invest and Trade</li>
<li>How Marvell Went From Short Target to Breakout Star</li>
<li>Procter &amp; Gamble NYSE: PG Pulls Back After Shaky Guidance</li>
<li>Palo Alto Networks: The All‑in‑One Cybersecurity Powerhouse</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票，胜过 Amedisys</li>
<li>高分红 REIT：它们是理想的多元化方式吗？</li>
<li>Visa 超过第三季度盈利预期，市场为何恐慌？</li>
<li>英国市场假期有哪些？如何投资和交易</li>
<li>Marvell 如何从短期目标变成突破明星</li>
<li>宝洁 NYSE: PG 在不稳定的指引后回落</li>
<li>Palo Alto Networks：全能网络安全巨头</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QU1FRA" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NASDAQ&amp;Symbol=AMED"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。如对该故事有任何问题或意见，请发送电子邮件至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in Amedisys Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 Amedisys 吗？</h2>
</div><p>Before you consider Amedisys, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考虑 Amedisys 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amedisys wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其向客户推荐的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 Amedisys 并不在名单上。</p>
</div><p>While Amedisys currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Amedisys 目前在分析师中获得了适度买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看这五只股票</p>
</div>

Wealthquest 公司在阿米斯医疗公司（纳斯达克股票代码：AMED）中建立了持仓